Supernus Pharmaceuticals Inc
SUPN
$42.00-2.14%
End of day · as of Sep 19, 2026, 6:31 PM ET
Mkt cap
$2.53B
EV/Sales
3.34
P/E ratio
N/A
FY2025 Revenue
$718.95M
EPS (TTM)
$-1.92
Gross Margin (FY2025)
89.63%
Profit Margin (FY2025)
-5.36%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported SUPN revenue for 2025-12-31 was $719.0M. Net income was -$38.5M. Revenue was up 8.6% from 2024-12-31 to 2025-12-31. SUPN currently screens at market cap $2.53B.
Use this SUPN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SUPN income, balance, and cash tables.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Supernus Pharmaceuticals Inc (SUPN) revenue for Dec 31, 2025 was $719.0M. Net income was -$38.5M. Statements: https://lician.com/financials/supn
Supernus Pharmaceuticals Inc (SUPN) market capitalization is $2.53B on the latest cached snapshot.
Supernus Pharmaceuticals Inc (SUPN) cached previous close $42.92; day range $41.60 – $42.89; volume 1,180,697. Session quote: https://lician.com/quote/supn
Supernus Pharmaceuticals Inc (SUPN) latest cached earnings event is "SUPN earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SUPN filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/supn